Enzo-logo-750-500.jpg
Enzo Biochem to Launch Monkeypox Testing Services this Week
August 11, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that its full-service...
Enzo-logo-750-500.jpg
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
August 03, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the addition of Matthew...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor
June 09, 2022 16:30 ET | Enzo Biochem, Inc.
Third quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic shutdowns in Asia Received approval from New York...
Enzo-logo-750-500.jpg
UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
June 06, 2022 08:30 ET | Enzo Biochem, Inc.
NEW YORK, NY, June 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2022 financial results...
Enzo-logo-750-500.jpg
Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
June 02, 2022 17:05 ET | Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
April 19, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, April 19, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced that it has received approval from...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
April 12, 2022 08:30 ET | Enzo Biochem, Inc.
FOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
April 06, 2022 16:57 ET | Enzo Biochem, Inc.
Meeting Scheduled for April 8, 2022 at 9:00 AM ET NEW YORK, NY, April 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022
April 01, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, April 01, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced its 2021 Annual Meeting of...
Enzo-logo-750-500.jpg
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
March 28, 2022 16:17 ET | Enzo Biochem, Inc.
NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced two key appointments to its...